Developer docs
API playgroundTry for free, no card

Search company profiles

VMLY&Rx

Full company profile

uuid0008myn

Namestring
VMLY&Rx
Legal namestring
VML
Websiteurl
vmlyrx.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

VMLY&Rx is the prescription pharmaceutical specialty division within VML Health, a global healthcare communications network owned by WPP. Founded in 2020 and headquartered in Cambridge, Massachusetts, the firm targets pharmaceutical and biotech companies developing breakthrough therapies, alongside healthcare systems and select health non-profits. It operates as a B2B professional services agency delivering brand experience, commerce, consulting, customer experience, and technology transformation services, supplemented by health-specific capabilities including early commercialization, health equity, medical communications, patient engagement and advocacy, and payer marketing. The division's stated differentiator is 'radical empathy' — a positioning emphasizing deep understanding of healthcare professionals and patient lived experiences.

The business generates revenue through project-based fees, retainers, and consulting engagements negotiated on a per-engagement basis, distributed via direct enterprise field sales and relationship-based account management. Delivery is executed through dedicated VML Health offices in New York, London (also the European hub), Manchester, Sydney, Shanghai, Tokyo, Madrid, Barcelona, Milan, Paris, Frankfurt, and Zurich, integrated within VML's broader 124-office global network. Named enterprise clients include Sanofi (global corporate reputation campaign), Bayer (women's health), biotech firm Aritium, and non-profits F**k Cancer and Europa Donna. Technology infrastructure leverages WPP Open and broader WPP data/AI capabilities; no proprietary AI platform or technology product is disclosed. The firm ranks #3 in MM+M's 2026 Top 100 Healthcare Marketing Companies and produces the annual Health Futures trend report as proprietary thought leadership IP.

Short descriptiontext

VMLY&Rx is the Rx pharmaceutical specialty division of WPP-owned VML Health, providing brand experience, commerce, consulting, and medical communications services to pharmaceutical, biotech, and healthcare system clients globally through dedicated offices across North America, Europe, and Asia-Pacific.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare communications, pharmaceutical marketing, medical communications, health brand strategy, patient engagement services
Industry1 code
1Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
CodeHLACAOAMPrimaryYes
NAICS code1 code
  • Custom Computer Programming Services541511
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Healthcare Communications Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Communications Services
TypeProfessional Services
Description

Professional services revenue model providing healthcare communications, brand experience, consulting, customer experience, and technology transformation services to pharmaceutical companies, biotech firms, and healthcare systems. Revenue is generated through project-based fees, retainers, and consulting engagements rather than product sales.

vml.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

VML Health (VMLY&Rx) is a global healthcare communications network that provides integrated marketing, brand experience, commerce, consulting, customer experience, and technology transformation services to pharmaceutical, biotech, and healthcare organizations. The agency combines creative communications, medical expertise, and patient-centric strategy to help clients navigate the complex healthcare landscape and drive measurable outcomes across the product lifecycle.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

VML Health is a global healthcare communications network that creates connected brands for life. The company operates as a unified platform integrating VML's core capabilities—Brand Experience, Commerce, Consulting, Customer Experience, and Technology Transformation—with specialized health sector focus. Additionally, VML Health offers health-specific services including Early Commercialization, Health Equity, Medical Communications, Patient Engagement & Advocacy, and Payer Marketing. The company also produces the annual Health Futures Report, which identifies key healthcare trends shaping the industry.

Product and service6 records
1Healthcare Marketing & Brand Communications
CategoryHealthcare Marketing
2Medical Communications
CategoryMedical Communications
3Patient Engagement Services
CategoryPatient Engagement
4Healthcare Consulting
CategoryConsulting
5Customer Experience & Technology Transformation
CategoryTechnology Transformation
6Market Access Communications
CategoryMarket Access
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

VML Health is a WPP company ('A WPP Company'). VML Health leverages WPP's broader technology infrastructure including WPP Open's AI capabilities for patient insights and outcomes optimization. This parent company relationship provides institutional backing and access to WPP's global resources and client network.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Publicis Groupe's healthcare communications arm and a direct holding-company peer. Competes head-to-head with VML Health on enterprise pharma pitches, medical communications, and patient engagement mandates.

TypeDirect peer
Description

Omnicom Group's healthcare marketing network and a structurally identical peer: a holding-company-owned, multi-agency healthcare communications platform serving the same enterprise pharmaceutical client base.

TypeBroad incumbent
Description

Sibling WPP agency focused on healthcare communications and public relations. Operates within VML Health's own parent network; competes for overlapping pharma/biotech PR and communications mandates while also serving as a potential partner.

TypeEmerging player
Description

Independent healthcare creative agency within the Omnicom network focused on specialty pharma and rare disease. Smaller in scale than VML Health but competes in the same high-value specialty pharma creative and brand engagement space.

TypeDirect peer
Description

Interpublic Group's dedicated healthcare communications network. Directly comparable as a holding-company-owned healthcare marketing specialist competing for the same global pharma clients and offering similar service breadth.

TypeDirect peer
Description

Global healthcare communications network and one of VML Health's most direct competitors. Both compete for the same enterprise pharma/biotech marketing mandates and offer comparable brand, medical communications, and patient engagement services at global scale.

TypeDirect peer
Description

Communications arm of Syneos Health, combining clinical/biopharmaceutical services with commercial communications. Comparable to VML Health on pharma commercialization, payer marketing, and medical communications work.

TypeDirect peer
Description

Independent healthcare media and communications agency specializing in pharma and biotech. Directly comparable on enterprise pharma media planning, HCP engagement, and multichannel campaign execution.

TypeDirect peer
Description

Havas' global healthcare communications network. Directly comparable in scope — multi-discipline pharma/biotech creative, medical communications, and patient engagement services for enterprise clients.

TypeDirect peer
Description

Healthcare marketing and communications specialist (formerly part of Huntsworth, now under CD&R ownership). Competes with VML Health for pharma enterprise mandates across brand, medical, and patient engagement.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VMLY&Rx

Healthcare Communications Servicesvmlyrx.com

VMLY&Rx is the Rx pharmaceutical specialty division of WPP-owned VML Health, providing brand experience, commerce, consulting, and medical communications services to pharmaceutical, biotech, and healthcare system clients globally through dedicated offices across North America, Europe, and Asia-Pacific.

What VMLY&Rx does

VMLY&Rx is the prescription pharmaceutical specialty division within VML Health, a global healthcare communications network owned by WPP. Founded in 2020 and headquartered in Cambridge, Massachusetts, the firm targets pharmaceutical and biotech companies developing breakthrough therapies, alongside healthcare systems and select health non-profits. It operates as a B2B professional services agency delivering brand experience, commerce, consulting, customer experience, and technology transformation services, supplemented by health-specific capabilities including early commercialization, health equity, medical communications, patient engagement and advocacy, and payer marketing. The division's stated differentiator is 'radical empathy' — a positioning emphasizing deep understanding of healthcare professionals and patient lived experiences.

The business generates revenue through project-based fees, retainers, and consulting engagements negotiated on a per-engagement basis, distributed via direct enterprise field sales and relationship-based account management. Delivery is executed through dedicated VML Health offices in New York, London (also the European hub), Manchester, Sydney, Shanghai, Tokyo, Madrid, Barcelona, Milan, Paris, Frankfurt, and Zurich, integrated within VML's broader 124-office global network. Named enterprise clients include Sanofi (global corporate reputation campaign), Bayer (women's health), biotech firm Aritium, and non-profits F**k Cancer and Europa Donna. Technology infrastructure leverages WPP Open and broader WPP data/AI capabilities; no proprietary AI platform or technology product is disclosed. The firm ranks #3 in MM+M's 2026 Top 100 Healthcare Marketing Companies and produces the annual Health Futures trend report as proprietary thought leadership IP.

VMLY&Rx firmographics

Firmographics
Name
VMLY&Rx
Legal name
VML
Website
https://vmlyrx.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
VMLY&Rx is the Rx pharmaceutical specialty division of WPP-owned VML Health, providing brand experience, commerce, consulting, and medical communications services to pharmaceutical, biotech, and healthcare system clients globally through dedicated offices across North America, Europe, and Asia-Pacific.
Ownership category
akta.pro rank

VMLY&Rx industry classification

Industry
Product category
Healthcare Communications Services
NAICS
Custom Computer Programming Services (541511)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro primary industry
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

  • Healthcare communications
  • Pharmaceutical marketing
  • Medical communications
  • Health brand strategy
  • Patient engagement services

Where VMLY&Rx is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices12 records

Markets served

VMLY&Rx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Healthcare Communications Services: Professional services revenue model providing healthcare communications, brand experience, consulting, customer experience, and technology transformation services to pharmaceutical companies, biotech firms, and healthcare systems. Revenue is generated through project-based fees, retainers, and consulting engagements rather than product sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

VMLY&Rx product offering

Product offering

Core offering

VML Health (VMLY&Rx) is a global healthcare communications network that provides integrated marketing, brand experience, commerce, consulting, customer experience, and technology transformation services to pharmaceutical, biotech, and healthcare organizations. The agency combines creative communications, medical expertise, and patient-centric strategy to help clients navigate the complex healthcare landscape and drive measurable outcomes across the product lifecycle.

Product overview

VML Health is a global healthcare communications network that creates connected brands for life. The company operates as a unified platform integrating VML's core capabilities—Brand Experience, Commerce, Consulting, Customer Experience, and Technology Transformation—with specialized health sector focus. Additionally, VML Health offers health-specific services including Early Commercialization, Health Equity, Medical Communications, Patient Engagement & Advocacy, and Payer Marketing. The company also produces the annual Health Futures Report, which identifies key healthcare trends shaping the industry.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare Marketing & Brand Communications
  • Medical Communications
  • Patient Engagement Services
  • Healthcare Consulting
  • Customer Experience & Technology Transformation
  • Market Access Communications

Companies that use VMLY&Rx

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

VMLY&Rx technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

VMLY&Rx partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • WPPcoreOthersVML Health is a WPP company ('A WPP Company'). VML Health leverages WPP's broader technology infrastructure including WPP Open's AI capabilities for patient insights and outcomes optimization. This parent company relationship provides institutional backing and access to WPP's global resources and client network.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

VMLY&Rx competitors and assessment

Company assessment

Direct peers

  • Publicis Health: Publicis Groupe's healthcare communications arm and a direct holding-company peer. Competes head-to-head with VML Health on enterprise pharma pitches, medical communications, and patient engagement mandates.
  • Omnicom Health Group: Omnicom Group's healthcare marketing network and a structurally identical peer: a holding-company-owned, multi-agency healthcare communications platform serving the same enterprise pharmaceutical client base.
  • IPG Health: Interpublic Group's dedicated healthcare communications network. Directly comparable as a holding-company-owned healthcare marketing specialist competing for the same global pharma clients and offering similar service breadth.
  • McCann Health: Global healthcare communications network and one of VML Health's most direct competitors. Both compete for the same enterprise pharma/biotech marketing mandates and offer comparable brand, medical communications, and patient engagement services at global scale.
  • Syneos Health Communications: Communications arm of Syneos Health, combining clinical/biopharmaceutical services with commercial communications. Comparable to VML Health on pharma commercialization, payer marketing, and medical communications work.
  • CMI Media Group: Independent healthcare media and communications agency specializing in pharma and biotech. Directly comparable on enterprise pharma media planning, HCP engagement, and multichannel campaign execution.
  • Havas Health & You: Havas' global healthcare communications network. Directly comparable in scope — multi-discipline pharma/biotech creative, medical communications, and patient engagement services for enterprise clients.
  • Evoke (Huntsworth): Healthcare marketing and communications specialist (formerly part of Huntsworth, now under CD&R ownership). Competes with VML Health for pharma enterprise mandates across brand, medical, and patient engagement.

Broad incumbents

  • GCI Health: Sibling WPP agency focused on healthcare communications and public relations. Operates within VML Health's own parent network; competes for overlapping pharma/biotech PR and communications mandates while also serving as a potential partner.

Emerging players

  • Biolumina: Independent healthcare creative agency within the Omnicom network focused on specialty pharma and rare disease. Smaller in scale than VML Health but competes in the same high-value specialty pharma creative and brand engagement space.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

VMLY&Rx social profiles

Digital presence

VMLY&Rx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VMLY&Rx leadership team

Management profile

Number of profiles

Profiles10 records

VMLY&Rx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VMLY&Rx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VMLY&Rx

What does VMLY&Rx do?

VML Health (VMLY&Rx) is a global healthcare communications network that provides integrated marketing, brand experience, commerce, consulting, customer experience, and technology transformation services to pharmaceutical, biotech, and healthcare organizations. The agency combines creative communications, medical expertise, and patient-centric strategy to help clients navigate the complex healthcare landscape and drive measurable outcomes across the product lifecycle.

Is VMLY&Rx a public or private company?

VMLY&Rx is a private company. It is classified as corporate owned and is currently operating.

When was VMLY&Rx founded?

VMLY&Rx was founded in 2020. It employs 5,001 to 10,000 people.

Where is VMLY&Rx based?

VMLY&Rx is headquartered in Cambridge, United States, in the North America region.

How does VMLY&Rx make money?

One revenue line is on record: healthcare Communications Services.

Who are VMLY&Rx's main competitors?

Direct peers on record are Publicis Health, Omnicom Health Group, IPG Health, McCann Health, Syneos Health Communications, CMI Media Group, Havas Health & You and Evoke (Huntsworth). GCI Health is listed as a broad incumbent. Biolumina is listed as an emerging player.

Does VMLY&Rx have an API?

No public API is recorded for VMLY&Rx.

What industry is VMLY&Rx in?

VMLY&Rx's product category is Healthcare Communications Services. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 541511 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales